Endoscopic submucosal dissection (ESD) is the standard technique for en-bloc resection of large colorectal lesions. 1 However, ESD may be technically challenging in the presence of submucosal fibrosis and poor visualization of the dissection plane. 2 Traction-assisted methods improve exposure of the submucosal layer and facilitate safer dissection. 3 Delayed bleeding remains one of the most relevant adverse events after rectal ESD, particularly in elderly patients receiving anticoagulant therapy, and no standard prophylactic strategy has yet been established. 4
We report the case of an 85-year-old man with anemia and hematochezia referred for ESD of a 70-mm JNET2B rectal non-granular pseudo-depressed laterally spreading tumor ( Fig. 1 ). His medical history included atrial fibrillation on direct oral anticoagulant therapy, ischemic heart disease, hypertension, and chronic kidney disease. The procedure was performed under spinal anesthesia. 5 Because of suspected submucosal fibrosis, traction-assisted ESD was planned ( Video 1 ).
Fig. 1.

Rectal non-granular pseudo-depressed laterally spreading tumor.
Video 1 Multidirectional traction-assisted rectal endoscopic submucosal dissection with prophylactic Glubran 2 nebulization.
After circumferential mucosal incision using a HybridKnife flex T-type (ERBE, Tubingen, Germany), the SureTrac traction system (Micro-Tech, Europe) was applied. This device consists of a primary clip connected to an elastic silicone band with four rings, allowing dynamic multidirectional traction and adjustment of the traction angle during dissection ( Figs. 2 and 3 ). The resulting tissue elevation provided excellent visualization of the submucosal layer, enabling safe en-bloc resection without intraprocedural adverse events ( Fig. 4 ). The total procedure time was 80 minutes.
Fig. 2.

First traction using the Suretrac system.
Fig. 3.

Second traction using the Suretrac system.
Fig. 4.

The en bloc resected specimen.
Considering the patient’s high bleeding risk and the need for early anticoagulation resumption, prophylactic Glubran 2 nebulization using an EndoNeb system (GEM, Italy) was applied over the resection bed ( Fig. 5 ). The patient was discharged the following day without complications or delayed bleeding. Histopathology revealed submucosal adenocarcinoma (pT1b, sm2, L0, V0, Bd1, R0, and G1). Multidisciplinary evaluation recommended clinical and endoscopic follow-up only.
Fig. 5.

Nebulization of Glubran 2 using an EndoNeb system over the resection bed.
This case highlights the usefulness of multidirectional traction-assisted ESD with SureTrac and suggests prophylactic Glubran 2 nebulization with the EndoNeb system as a promising strategy to reduce delayed bleeding in high-risk patients.
UCTN Code: Endoscopy_UCTN_Code_TTT_1AQ_2AC
Declaration of GenAI Use
Generative artificial intelligence (ChatGPT) was used solely for English language translation and linguistic assistance during the preparation of this manuscript.
Footnotes
Conflict of Interest The authors declare that they have no conflict of interest.
Contributorsʼ Statement Giuliano Francesco Bonura: conceptualization, data curation, formal analysis, methodology, validation, visualization, writing – original draft, and writing – review and editing. Giulia Bertoncini: investigation, methodology, software, writing – original draft, and writing – review and editing. Federica Indulti: data curation, validation, and writing – original draft. Giovanni Aragona: supervision, validation, and writing – review and editing. Chiara Salvatore: data curation, investigation, and resources. Paola Soriani: methodology, visualization, writing – review and editing. Mauro Manno: conceptualization, supervision, validation, visualization, and writing – review and editing.
References
- 1.Pimentel-Nunes P, Libânio D, Bastiaansen BA J, Bhandari P, Bisschops R, Bourke M J et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) guideline – update 2022. Endoscopy. 2022;54(06):591–622. doi: 10.1055/a-1811-7025. [DOI] [PubMed] [Google Scholar]
- 2.Matsumoto A, Tanaka S, Oba S, Kanao H, Oka S, Yoshihara M et al. Outcome of endoscopic submucosal dissection for colorectal tumors accompanied by fibrosis. Scand J Gastroenterol. 2010;45(11):1329–1337. doi: 10.3109/00365521.2010.495416. [DOI] [PubMed] [Google Scholar]
- 3.Libânio D, Pimentel-Nunes P, Bastiaansen B, Bisschops R, Bourke M J, Deprez P H et al. Endoscopic submucosal dissection techniques and technology: European Society of Gastrointestinal Endoscopy (ESGE) technical review. Endoscopy. 2023;55(04):361–389. doi: 10.1055/a-2031-0874. [DOI] [PubMed] [Google Scholar]
- 4.Murata M, Sugimoto M, Ueshima S, Nagami Y, Ominami M, Sawaya M et al. Association of direct oral anticoagulant and delayed bleeding with pharmacokinetics after endoscopic submucosal dissection. Gastrointest Endosc. 2024;99(05):721–7.31E6. doi: 10.1016/j.gie.2023.11.048. [DOI] [PubMed] [Google Scholar]
- 5.Bonura G F, Biancheri P, Rainer J, Soriani P, Rodriguez De Santiago E, Parrella A et al. Spinal anesthesia for endoscopic submucosal dissection of large rectosigmoid lesions: feasibility study. Endosc Int Open. 2024;12(12):E1447–E1452. doi: 10.1055/a-2441-2543. [DOI] [PMC free article] [PubMed] [Google Scholar]
